CME Group/$CME

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About CME Group

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

Ticker

$CME
Sector
Primary listing

Employees

3,760

CME Group Metrics

BasicAdvanced
$97B
25.94
$10.33
0.44
$10.70
1.87%

What the Analysts think about CME Group

Analyst ratings (Buy, Hold, Sell) for CME Group stock.

Bulls say / Bears say

CME Group beat analyst expectations in Q2 2025, posting $1.07 billion in net profit and record average daily volumes of 30.2 million contracts, fueled by heightened volatility and increased new retail trading. (Reuters)
In Q1 2025, CME set a revenue record at $1.64 billion, up 10% from a year earlier, and grew profit 12% to $956 million. Contract volumes averaged 29.8 million daily, a 13% jump. (Reuters)
CME’s planned rollout of cash-settled XRP futures on May 19, 2025, pending regulatory nod, broadens its cryptocurrency suite and addresses rising institutional and retail interest beyond Bitcoin and Ether. (Reuters)
Operating expenses unexpectedly rose by 1.1% to $534.4 million in Q1 2025, led by increased technology investments. This caused EPS to narrowly miss expectations and could squeeze margins if costs keep rising. (Reuters)
CME may face challenges from new rivals in derivatives clearing, especially with the launch of FMX Futures by BGC Group, potentially reducing market share and pressuring trading fees. (Reuters)
Even though CME’s share price climbed 18.3% in 2025, it lagged behind Cboe Global and Intercontinental Exchange, fueling concerns about valuation and investor preference. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2025.

CME Group Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

CME Group Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CME

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs